MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francken, B. J. B.
Right arrow Articles by Leysen, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francken, B. J. B.
Right arrow Articles by Leysen, J. E.

Vol. 57, Issue 5, 1034-1044, May 2000


Human 5-Hydroxytryptamine5A Receptors Activate Coexpressed Gi and Go Proteins in Spodoptera frugiperda 9 Cells

Bart J. B. Francken, Katty Josson, Peter Lijnen, Mirek Jurzak, Walter H. M. L. Luyten, and Josée E. Leysen

Departments of Biochemical Pharmacology (B.J.B.F., K.J., P.L., M.J., J.E.L.) and Functional Genomics (W.H.M.L.L.), Janssen Research Foundation, Beerse, Belgium

    Abstract
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

The ability of the human 5-hydroxytryptamine serotonin type 5A (h5-ht5A) receptor to couple to G proteins from distinct families was investigated through the simultaneous infection of Spodoptera frugiperda 9 insect cells with recombinant baculoviruses encoding the various proteins. Expression of G proteins was demonstrated in immunoblots. Receptor-G protein coupling was monitored by high-affinity agonist binding and agonist-induced stimulation of [35S]guanosine-5'-O-(3-thio) triphosphate binding to membranes. Receptors expressed alone displayed low-affinity agonist binding, and endogenous G proteins were only poorly stimulated on the addition of 5-hydroxytryptamine. When receptors were coexpressed with mammalian Gi/Go proteins (Galpha i or Galpha o plus Gbeta 1gamma 2), the coupled phenotype was achieved: agonists bound with high affinity in a guanosine-5'-(beta ,gamma -imido)triphosphate-sensitive manner and stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding to high levels. These effects were not observed on coexpression with Gz/Gs/Gq/11/16 or G12/13. Various ligands were evaluated for their agonistic, antagonistic, or inverse agonistic behavior in both receptor binding and activation assays. Although Go displayed different receptor coupling characteristics than Gi proteins, no clear coupling preference was evident. Coexpression of receptors and Galpha i subunits without Gbeta 1gamma 2 produced increases in both agonist affinity and maximum G protein activation that were smaller than those in the presence of Gbeta 1gamma 2, suggesting that Gbeta 1gamma 2 coexpression improves receptor-G protein coupling. Similarly, coexpression of receptors with Gbeta 1gamma 2 alone resulted in an improved interaction with endogenous G proteins. Our results demonstrate that h5-ht5A receptors expressed in Spodoptera frugiperda 9 cells selectively and functionally couple to coexpressed mammalian Gi and Go proteins.

    Introduction
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

5-Hydroxytryptamine (5-HT) is a neurotransmitter that affects diverse physiological processes, including sleep, sexual behavior, food intake, locomotion, and mood. Schizophrenia, depression, and migraine are among the pathological conditions that are associated with a dysfunction of 5-HT transmission. At least 13 different 5-HT receptors have been identified to date. They belong to the superfamily of seven-transmembrane-domain receptors that couple to heterotrimeric guanine nucleotide-binding proteins (G proteins), with the exception of the 5-ht3 receptor, which forms a 5-HT-gated ion channel (for review, Saudou and Hen, 1994; Hoyer and Martin, 1997).

The 5-ht5A and 5-ht5B receptors of the 5-ht5 receptor subfamily were first identified in mice (Plassat et al., 1992; Matthes et al., 1993) and subsequently in rats (Erlander et al., 1993). Rees et al. (1994) cloned the human 5-ht5A receptor (h5-ht5A) homolog, but a 5-ht5B receptor does not seem to be functionally expressed in humans (Rees et al., 1994). The physiological function of 5-ht5 receptors is still unclear, partly due to a lack of specific ligands. Recently, results obtained with transgenic mice lacking the 5-ht5A receptor gene suggested the involvement of the receptor subtype in exploratory behavior (Grailhe et al., 1999). The mouse, rat, and human 5-ht5 receptors have already been expressed in various cell lines. Initially, no effects on signal transduction systems could be demonstrated (Erlander et al., 1993; Matthes et al., 1993), although agonist binding to the recombinant receptor was found to be guanine nucleotide-sensitive (Plassat et al., 1992). Negative coupling to adenylate cyclase activity was first reported for the rat 5-ht5A receptor expressed in C6 glioma cells (Carson et al., 1996). Recently, agonist-induced inhibition of adenylate cyclase activity was also demonstrated for the human 5-ht5A receptor expressed in human embryonic kidney (HEK) 293 cells (Francken et al., 1998; Hurley et al., 1998). In studies of agonistinduced stimulation of [35S]guanosine-5'-O-(3-thio)triphosphate ([35S]GTPgamma S) binding, h5-ht5A receptors expressed in HEK 293 cells were shown to couple to pertussis toxin-sensitive G proteins (Francken et al., 1998).

The Spodoptera frugiperda 9 (Sf9) insect cell/baculovirus system has already been successfully used to reconstitute the interaction of various G protein-coupled receptors with their cognate G proteins (Butkerait et al., 1995; Grünewald et al., 1996; Barr et al., 1997). When expressed in Sf9 cells at high levels, heterologous receptors display a predominantly uncoupled phenotype in the absence of recombinant G proteins due to the low background of endogenous G proteins (Butkerait et al., 1995; Boundy et al., 1996; Ohtaki et al., 1998). Therefore, receptor-G protein coupling specificity can be examined by coexpression in Sf9 cells of the receptor proteins with a series of G protein subtypes, through simultaneous infection with the appropriate recombinant baculoviruses. Successful receptor-G protein interaction is characterized by high-affinity and guanine nucleotide-sensitive agonist binding and by receptor-mediated activation of G proteins, as measured by agonist-stimulated [35S]GTPgamma S binding or GTPase activity.

To evaluate the G protein-coupling profile of the h5-ht5A receptor in detail, we coexpressed combinations of receptor, G protein beta 1gamma 2 dimer (Gbeta 1gamma 2), and various G protein alpha -subunits (Galpha subunits) in Sf9 insect cells. We measured the receptor coupling to members of each of the four families of G proteins using radioligand binding and [35S]GTPgamma S binding to membranes and investigated the pharmacological properties of various 5-HT receptor ligands. It was found that the h5-ht5A receptor selectively couples to Galpha i/o proteins and that coexpression of the Gbeta 1gamma 2 dimer facilitates receptor-G protein coupling.

    Experimental Procedures
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Materials. Sf9 insect cells were obtained from Invitrogen (Groningen, The Netherlands). The baculovirus transfer vector pAcGP67A and the BaculoGold DNA were purchased from PharMingen (San Diego, CA). The transfer vector pBacPAK9 was obtained from Clontech Laboratories (Palo Alto, CA). [3H]5-Carboxamidotryptamine (5-CT; 50-100 Ci/mmol), [35S]GTPgamma S (>1000 Ci/mmol), and the chemiluminescent Western detection kit (ECL-Plus) were purchased from Amersham Pharmacia Biotech (Little Chalfont, UK). 5-HT, 5-methoxytryptamine (5-MT), and dihydroergotamine (DHE) were purchased from Acros Organics (Geel, Belgium). Lysergic acid diethylamide (LSD) was obtained from Kenija Industriji (Yugoslavia). 5-CT was obtained from Research Biochemicals Inc. (Natick, MA). Methiothepin was purchased from Hoffman-La Roche (Basel, Switzerland). Pargyline was purchased from Sigma-Aldrich (St. Louis, MO). Grace's supplemented insect cell culture medium, Sf-900 II serum-free insect cell culture medium, and antibiotic/antimycotic solution were obtained from Life Technologies (Gaithersburg, MD). Fetal bovine serum was purchased from BioWhittaker (Walkersville, MD). The protein assay kit and the protein molecular weight marker were obtained from Bio-Rad Laboratories (Hercules, CA). Guanosine-5'-(beta ,gamma -imido)triphosphate (Gpp(NH)p) and GDP were obtained from Boehringer-Mannheim (Mannheim, Germany). The anti-Galpha i/o/t/z/s rabbit antiserum was purchased from Calbiochem (La Jolla, CA). The rabbit antisera for Galpha q/11, Galpha 12, and Galpha 13 were obtained from Chemicon International (Temecula, CA). The goat antiserum for Galpha 16 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The peroxidase-conjugated anti-rabbit and anti-goat secondary antibodies were obtained from Jackson ImmunoResearch Laboratories (West Grove, PE).

5-HT, 5-CT, and 5-MT were dissolved and diluted in assay buffer. DHE, LSD, and methiothepin were dissolved and diluted in DMSO; the last 20-fold dilution step was performed in assay buffer. The dilution in the assay mixture was 10-fold. In all control assays, DMSO was added to a final concentration of 0.5%.

Baculoviruses containing cDNA-encoding rat Galpha i1, Galpha i2, Galpha i3, and Galpha o subunits were gifts from Dr. J. Garrison (University of Virginia) (Graber et al., 1992). The baculovirus for human Galpha z was a gift from Dr. D. Manning (University of Pennsylvania) (Butkerait et al., 1995). Baculoviruses for bovine Galpha s-short-B, mouse Galpha q, mouse Galpha 11, and human Galpha 16 were gifts from Dr. A. Gilman and Dr. T. Kozasa (University of Texas) (Hepler et al., 1993; Kozasa et al., 1993; Linder et al., 1993). Baculoviruses for mouse Galpha 12 and Galpha 13 were gifts from Dr. D. Dhanasekaran (Temple University, PA). The bovine Gbeta 1gamma 2 transfer vector was a gift from Dr. T. Haga (University of Tokyo, Japan) (Nakamura et al., 1995).

Cloning of h5-ht5A Receptor cDNA. The coding region of the human 5-ht5A receptor was amplified from a QuickScreen cDNA library (Clontech) by polymerase chain reaction using primers 5'-GCGATATGGACCCAGAGATGGATTTACCAGTGAACC-3' and 5'-GCCTCGAGCCTCAGTGTTGCCTAGAAAAGAAGTTCTTG-3'. The inclusion of restriction sites (EcoRV and XhoI) within the oligonucleotide primers allowed cloning of the polymerase chain reaction fragment into the pcDNA3 vector (Invitrogen). The sequence of the insert was identical to that reported by Hurley et al. (1998) and contained a single silent mutation (T to C at nucleotide 300, counting from the A of the start codon), compared with the sequence deposited in the GenBank/EMBL database (accession numbers X81411 and X81412) by Rees et al. (1994).

Construction of Recombinant Transfer Vector. The h5-ht5A cDNA clone in pcDNA3 was digested with PstI, blunt-ended with Klenow DNA polymerase, and digested with XbaI, yielding a 1145-bp fragment encoding the h5-ht5A receptor. This fragment was subcloned into the BamHI (filled in with Klenow DNA polymerase) and XbaI positions of the multiple cloning site of the baculovirus transfer vector pAcGP67A, such that the gp67 signal sequence was fused in frame to the N terminus of the h5-ht5A coding sequence via a nine-amino acid linker sequence (gp67-ADRCDMDPE-h5-ht5A). For the pBacPAK9-based transfer vector, the h5-ht5A cDNA was excised from the pcDNA3 clone by digestion with EcoRI and XhoI. The 1142-bp fragment encoding the h5-ht5A receptor was subcloned into the multiple cloning site of the transfer vector pBacPAK9 that was digested with the same restriction enzymes. Protein expression was under control of the polyhedrin promoter in both transfer vectors. The DNA insert sequences were confirmed by sequencing both strands of the double-stranded DNA.

Generation of Recombinant Baculoviruses. Transfer of the h5-ht5A receptor cDNA into the wild-type Autographa californica nuclear polyhedrosis virus genome was accomplished by homologous recombination. Sf9 insect cells were cotransfected with linearized modified A. californica nuclear polyhedrosis virus baculovirus DNA (BaculoGold) and the h5-ht5A-containing recombinant transfer vector using standard techniques (O'Reilly et al., 1992). Purification of recombinant viruses, amplification of purified virus stocks, and determination of virus titers were performed as described by O'Reilly et al. (1992).

Insect Cell Culture and Baculovirus Infection. Sf9 cells were grown at 27°C and at an ambient atmosphere in suspension culture using spinner flasks or in monolayers. For viral stock production, Grace's insect cell culture medium was used supplemented with 10% fetal bovine serum, 0.2 mM L-glutamine, and 1% antibiotic/antimycotic solution, whereas Sf-900 II serum-free insect cell culture medium, supplemented with 0.2 mM L-glutamine and 1% antibiotic/antimycotic solution, was used in recombinant protein expression experiments. Cell viability was determined by trypan blue staining. Cells (50-500 ml) at a density of 1 × 106 cells/ml (log phase growth) were infected with a h5-ht5A receptor-encoding baculovirus at a multiplicity of infection (m.o.i.) of 2 (unless stated otherwise), with a Gbeta 1gamma 2-encoding virus (m.o.i. = 1) and/or with a Galpha -encoding virus (m.o.i. = 2-4). For the expression of single Galpha subunits, the m.o.i. was 4 for any Galpha baculovirus, whereas for the expression of multiple Galpha subunits (Galpha i1, Galpha i2, Galpha i3, and Galpha o, abbreviated as Galpha i/o) the m.o.i. was 2 for each virus. At 48 h postinfection, cells were harvested by centrifugation (10 min at 2000g at 4°C), washed with ice-cold PBS, and stored at -80°C or used directly for membrane preparation.

Membrane Preparation and Determination of Protein Content. Harvested Sf9 cells were washed with ice-cold 50 mM Tris-HCl buffer, pH 7.4; resuspended in hypotonic 10 mM Tris-HCl buffer, pH 7.4; and homogenized with an UltraTurrax homogenizer (Janke and Kunkel, Staufen, Germany) for 5 s. The homogenate was centrifuged at 30,000g for 20 min at 4°C. The membrane pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.4, containing 10% glycerol and stored in aliquots at -80°C. Protein content in membrane preparations was estimated with the Bradford protein assay (Bradford, 1976), using the Bio-Rad kit. BSA was used as a standard.

Immunoblot Analysis. Membrane protein (1, 4, or 10 µg) was incubated in 62.5 mM Tris-HCl buffer, pH 6.8, containing 10% glycerol, 5% SDS, and 0.01% bromophenol blue at 37°C for 2 h. Proteins were separated by SDS-polyacrylamide gel electrophoresis and were transferred to polyvinylidene-difluoride membranes, using standard techniques. Immunodetection of Galpha subunits was performed with 1:1000 dilutions of the Galpha i/o/t/z/s, Galpha q/11, Galpha 16, Galpha 12, and Galpha 13 antisera. The peroxidase-conjugated anti-rabbit and anti-goat secondary antibodies were diluted 1:5000. Bands were visualized by chemiluminescence using the ECL-Plus detection kit.

Radioligand Binding. [3H]5-CT binding experiments were performed essentially as described previously (Francken et al., 1998). Briefly, 6 µg of membrane protein was diluted in 50 mM Tris-HCl buffer, pH 7.4, containing 10 mM MgCl2, 1 mM EGTA, and 10 µM pargyline and incubated with [3H]5-CT for 1 h at 25°C in a volume of 0.5 ml. Nonspecific binding was estimated in the presence of 10 µM methiothepin. Reactions were terminated by rapid filtration through glass fiber (GF/B) filters (Whatman, Kent, UK) presoaked in 0.1% polyethyleneimine using a Brandel (Gaithersburg, MD) 96-sample harvester. Filters were washed twice, and filter-bound radioactivity was counted in a liquid scintillation spectrometer (Tricarb) using scintillation fluid (Ultima Gold MV; Packard Instrument Company, Meriden, CT). For radioligand concentration-binding isotherms, 12 concentrations of [3H]5-CT, in a range of 0.1 to 25 nM, were used. Competition binding experiments were performed using 2 nM [3H]5-CT; compounds were added at 7 to 12 concentrations.

[35S]GTPgamma S Binding. [35S]GTPgamma S binding experiments were performed as previously described (Francken et al., 1998). Briefly, 12 µg of membrane protein was diluted in 50 mM Tris-HCl buffer, pH 7.4, containing 50 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 0.1 mM dithiothreitol, 10 µM pargyline, and 1 µM GDP and preincubated with compound for 30 min at 30°C in a volume of 0.45 ml. Then, 50 µl of [35S]GTPgamma S in assay buffer was added to a final concentration of 0.2 nM, and the assay mixtures were further incubated for 30 min at 30°C. Reactions were terminated by rapid filtration through GF/B filters, presoaked in assay buffer, using a 40-well manual filtration manifold or a Brandel 48-sample harvester. Filters were washed twice, and filter-bound radioactivity was counted in a liquid scintillation spectrometer. Basal [35S]GTPgamma S binding was measured in the absence of compound. Compounds were added at 9 to 11 concentrations. Nonspecific [35S]GTPgamma S binding, as measured in the presence of 100 µM GTPgamma S, did not exceed 10% of basal binding and was never subtracted from experimental data.

Data Analysis. Radioligand concentration-binding isotherms (rectangular hyperbola) were calculated by nonlinear regression analysis according to algorithms described by Oestreicher and Pinto (1987), and sigmoidal inhibition curves were calculated by nonlinear regression using the Prism program (GraphPad Software, San Diego, CA). Bmax and Kd values of the radioligand and IC50 values of inhibitors were derived from the curve fitting.

Stimulation of [35S]GTPgamma S binding was calculated as 100 times the difference between stimulated and basal binding (in cpm) divided by the amount of basal binding (in cpm). Agonist concentration-response curves and antagonist inhibition curves were analyzed by nonlinear regression using GraphPad Prism. EC50 and IC50 values were derived from the curves. IC50 values were corrected as follows: corrected IC50 (IC50-corr) = IC50/{1 + [5-HT]/EC50(5-HT)}. Relative maximum stimulation (Emax) values were calculated as percentage of the maximum stimulation obtained with 10 µM 5-HT, and relative maximum inhibition (Imax) values were calculated as percentage of the inhibition from maximum 5-HT (10 µM)-stimulated [35S]GTPgamma S binding to basal level.

Statistical F tests and Student's t tests were performed, and all figures were prepared using GraphPad Prism.

    Results
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Expression of h5-ht5A Receptors and G Protein Subunits in Sf9 Insect Cells. The h5-ht5A receptor coding sequence was cloned from a cDNA library, and recombinant baculoviruses were generated and used to infect Sf9 cells. In preliminary [3H]5-CT concentration-binding experiments on membranes of Sf9 cells infected at an m.o.i. of 3, higher expression levels were found for virus generated with the pAcGP67A transfer vector (Bmax = 63 ± 11 pmol/mg protein, Kd = 10.1 ± 2.0 nM, mean ± S.D., n = 5) than for pBacPAK9-based virus (Bmax = 23 ± 2 pmol/mg protein, Kd = 5.6 ± 1.0 nM, n = 3), probably due to the presence of the gp67 signal sequence. No specific [3H]5-CT binding could be detected to membranes of uninfected or wild-type baculovirus-infected cells (data not shown). Further expression experiments were performed with the pAcGP67A-based virus at an m.o.i. of 2.

The effect of coexpression of various G protein subunits (m.o.i. = 1-4) on the affinity of [3H]5-CT for the h5-ht5A receptor was determined using [3H]5-CT concentration-binding experiments. Examples of [3H]5-CT saturation curves are presented in Fig. 1. Table 1 summarizes the mean Kd and Bmax values and shows the binding data for h5-ht5A-HEK 293 cell membranes for comparison (Francken et al., 1998). All [3H]5-CT concentration-binding isotherms were best fitted to a one-binding-site model compared with a two-binding-site model, using nonlinear regression (F test, P > .05). Receptors expressed alone in Sf9 cells yielded a Bmax value of 39 ± 12 pmol/mg protein and a Kd value of 7.8 ± 0.9 nM, which is a Kd value similar to that of the low-affinity form of the receptor in h5-ht5A-HEK 293 cells. Coexpression of receptors with Gbeta 1 and Ggamma 2 (Gbeta 1gamma 2 baculovirus, m.o.i. = 1) resulted in a slight, but statistically significant, increase in [3H]5-CT affinity (Student's t test, P < .05) (Fig. 1A, Table 1), suggesting improved coupling of the recombinant receptors to endogenous G proteins. Coexpression of h5-ht5A receptors with Galpha i1, Galpha i2, or Galpha i3 (m.o.i. = 4) or with a mixture of Galpha i1, Galpha i2, Galpha i3, and Galpha o (further designated as Galpha i/o; m.o.i. = 2 for each virus) also significantly increased [3H]5-CT affinity (Student's t test, P < .05) (Fig. 1B), whereas no effect was observed with Galpha o, Galpha z, Galpha s, Galpha 11, Galpha 16, Galpha 12, or Galpha 13 subunits (Table 1). The small, but statistically significant, increase in [3H]5-CT affinity that was observed on coexpression with Galpha q is considered as a spurious finding, considering the lack of a Gpp(NH)p effect on agonist binding (Table 1, see Fig. 4). When Gbeta 1gamma 2 subunits (m.o.i. = 1) were expressed in addition to Galpha subunits and receptors, [3H]5-CT affinities further increased for Galpha i/o, Galpha i1, Galpha i2, Galpha i3, and Galpha o (Student's t test, P < .05) (Fig. 1B) but not for Galpha z, Galpha s, Galpha q, Galpha 11, Galpha 16, Galpha 12, or Galpha 13 (Table 1).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Concentration-binding isotherms and Scatchard plots (insets) of specific [3H]5-CT binding to membranes of baculovirus-infected Sf9 insect cells expressing h5-ht5A receptors alone (A, black-square) or with Gbeta 1 and Ggamma 2 subunits (A, ) or coexpressing h5-ht5A receptors with Galpha i1 alone (B, ) or Galpha i1 with Gbeta 1 and Ggamma 2 (B, open circle ). The data represent mean values of duplicate determinations from a typical experiment of three to six independent experiments. Sf9 cells were harvested after 48-h infection with a set of baculoviruses encoding the h5-ht5A receptor (m.o.i. = 2), Galpha subunits (m.o.i. = 4), and/or Gbeta 1gamma 2 subunits (m.o.i. = 1). Radioligand binding studies were performed on membranes as described in Experimental Procedures. Isotherms were best fitted to a one-binding-site model using nonlinear regression analysis. Bmax and Kd values were derived for each individual experiment, and mean values are summarized in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Kd and Bmax values for [3H]5-CT binding to membranes of Sf9 cells coexpressing the h5-ht5A receptor and G protein subunits of the Gi/o, Gs, Gq/11, and G12/13 family

Radioligand binding studies were performed, and Kd and Bmax values were derived as described in Experimental Procedures. The results are mean ± S.D. values from n independent experiments.

The expression of recombinant Galpha subunits was verified by immunoblot analysis using commercially available antibodies. Figure 2 shows immunoblots for the membranes of Sf9 cells expressing receptor and mammalian G protein trimers. For the different Galpha proteins, immunoreactivity was demonstrated in the respective experimental membranes. It should be noted that using the same antiserum directed against a common peptide sequence, the immunoreactivity for Galpha o was much stronger than that for the Galpha i subunits, suggesting higher Galpha protein expression levels.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2.   Immunoblot analysis of baculovirus-infected Sf9 membranes using anti-Galpha subunit antisera. The analysis was performed on membranes of Sf9 cells infected with wild-type baculovirus (pAcNPV) or a combination of recombinant baculoviruses encoding h5-ht5A receptor and/or Gi1, Gi2, Gi3, Go, Gz, Gs, Gq, G11, G16, G12, or G13 heterotrimers (Galpha beta 1gamma 2), as indicated above each lane. The antisera that were used to visualize expression of the mammalian Galpha proteins are indicated at the right of the bands, whereas the positions of the molecular weight marker proteins are indicated at the left. The anti-Galpha i/o/t/z/s antiserum was tested on 4 µg of membrane protein, anti-Galpha q/11 antiserum was tested on 1 µg, and anti-Galpha 16, anti-Galpha 12, and anti-Galpha 13 antisera were tested on 10 µg of membrane protein. Gi/o represents the simultaneous expression of Gi1, Gi2, Gi3, and Go proteins.

In the presence of the individual Gi or Go trimers, the affinity of [3H]5-CT was intermediate to that of the high- and low-affinity forms of the receptor in stably transfected HEK 293 cells (Francken et al., 1998). Only with the simultaneous expression of a mixture of Gi and Go proteins (Gi/o) did the affinity of [3H]5-CT equal that for the high-affinity state of the receptor, probably due to the occurrence of a lower receptor-to-G protein ratio. Indeed, the infection of Sf9 cells with baculoviruses encoding each of the four G protein subtypes resulted in a relatively low level of receptor binding sites (Table 1), and the high m.o.i. for the Galpha protein-encoding baculoviruses implicates an increased overall number of G proteins (Fig. 2). Alternatively, coexpression with the mixture of Gi/o proteins might mimic a more natural situation, in which the receptor is able to interact with all of the used G protein subtypes. It should be noted that a decrease in receptor number was not systematically observed on coexpression with G protein subunits. For example, coexpression with Galpha q and Gbeta 1gamma 2 resulted in a Bmax value that was higher than when the receptor was expressed alone (Table 1). Differences in receptor expression levels between similar experiments were also observed by other groups (Butkerait et al., 1995) and are difficult to explain.

Pharmacological Characterization of h5-ht5A Receptors Expressed Alone or Coexpressed with G Protein Subunits. Various 5-HT receptor ligands were used to inhibit [3H]5-CT binding to membranes of baculovirus-infected Sf9 insect cells. pIC50 values were derived from inhibition curves and are summarized in Table 2. The pharmacological profile of h5-ht5A receptors expressed alone in Sf9 cells was different from that in stably transfected h5-ht5A-HEK 293 cells; the agonists 5-CT, 5-HT, and 5-MT had 3.2- to 3.6-fold lower affinities (Student's t test, P < .05), whereas DHE, LSD, and methiothepin had slightly higher affinities for the receptor expressed alone in Sf9 cells. The rank order of potency of the tested compounds was LSD > methiothepin > 5-CT > DHE > 5-HT > 5-MT. This profile did not change on coexpression with Gbeta 1gamma 2 subunits, although agonist affinities were slightly, but never significantly, increased.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Inhibition by various 5-HT receptor ligands of [3H]5-CT (2 nM) binding to membranes of Sf9 cells coexpressing the h5-ht5A receptor and G protein subunits of the Gi/o and Gs family

Radioligand binding studies were performed as described in Experimental Procedures, and pIC50 (-logM) values were derived from individual curves. Results are mean pIC50 ± S.D. values from n independent experiments.

The simultaneous expression of receptor and Gbeta 1gamma 2 together with Galpha i1, Galpha i2, Galpha i3, Galpha o, or the mixture of Galpha i/o subunits, but not together with Gz or Gs, resulted in an increase in the agonist affinities; the pIC50 values were very similar to those for h5-ht5A-HEK 293 membranes (Student's t test, P > .05) (Table 2). Figure 3 compares the inhibition curves of the tested compounds for Sf9 cells expressing the h5-ht5A receptor alone and in combination with Galpha i1 and Gbeta 1gamma 2. In contrast to the agonists, the affinity of methiothepin significantly decreased up to 1 log unit on coexpression of Gi/Go proteins. Decreases in DHE and LSD affinities were minor on coexpression of individual Gi or Go proteins but appeared significant on coexpression of the mixture of Gi/o proteins.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibition of [3H]5-CT (2 nM) binding to membranes of baculovirus-infected Sf9 insect cells expressing h5-ht5A receptors alone (, black-square) or together with Galpha i1 and Gbeta 1gamma 2 subunits (open circle , ). A, 5-HT (, open circle ) and LSD (black-square, ). B, 5-CT (, open circle ) and DHE (black-square, ). C, 5-MT (, open circle ) and methiothepin (black-square, ). Depicted points are mean ± S.D. values of three to seven independent experiments. Mean values of pIC50 values derived from individual curves are given in Table 2. Baculovirus infection of Sf9 cells and radioligand binding studies were performed as described in Experimental Procedures.

Effect of Gpp(NH)p on [3H]5-CT Binding. The interaction of h5-ht5A receptors with endogenous or coexpressed G proteins in membranes of baculovirus-infected Sf9 cells was investigated by measuring the sensitivity of agonist binding to the addition of the nonhydrolyzable GTP analog Gpp(NH)p. [3H]5-CT concentration-binding experiments in the presence and absence of 100 µM Gpp(NH)p were performed in parallel, and the Kd values were compared using a paired Student's t test (Table 1). Figure 4 visualizes the ratio of Kd values for [3H]5-CT binding in the presence and absence of Gpp(NH)p. The affinity of [3H]5-CT observed for the h5-ht5A receptor expressed alone was unaffected by Gpp(NH)p, suggesting the absence of interaction with endogenous G proteins. The small increase in affinity achieved by Gbeta 1gamma 2 coexpression was completely reversed by Gpp(NH)p. The affinity of [3H]5-CT significantly decreased on Gpp(NH)p addition to membranes of Sf9 cells coexpressing the h5-HT5A receptor together with Gbeta 1gamma 2 and either the Galpha i/o mixture, Galpha i1, Galpha i2, Galpha i3, or Galpha o, whereas no significant decrease in affinity was observed for the other G protein coexpressions (Fig. 4).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Gpp(NH)p sensitivity of [3H]5-CT binding to membranes of Sf9 cells coexpressing h5-ht5A receptors and diverse G protein subunits. The data represent the mean ratios (±S.D.) of the Kd values for [3H]5-CT in the presence of 100 µM Gpp(NH)p versus the Kd values for [3H]5-CT in the absence of Gpp(NH)p. Concentration-binding experiments were performed in parallel in the absence and presence of 100 µM Gpp(NH)p as described in Experimental Procedures. Bmax and Kd values were derived for each individual experiment, and mean values are summarized in Table 1. For each individual experiment, the ratio was calculated of the Kd value in the presence versus that in the absence of 100 µM Gpp(NH)p. Comparisons were made using the paired two-tailed Student's t test. *Significant (Student's t test, P < .05) difference in Kd value for [3H]5-CT in the presence versus in the absence of 100 µM Gpp(NH)p.

5-HT-Stimulated [35S]GTPgamma S Binding. Receptor-mediated activation of G proteins was examined by concentration-dependent 5-HT-stimulated binding of [35S]GTPgamma S to membranes of baculovirus-infected Sf9 cells. The activation of G proteins involves stimulation of GDP/GTP exchange at the Galpha subunit and can be measured by the incorporation of the nonhydrolyzable GTP analog [35S]GTPgamma S (Wieland and Jakobs, 1994). Figure 5 depicts the dose-dependent increase in 5-HT-stimulated [35S]GTPgamma S binding for Sf9 cells expressing h5-ht5A receptors alone or together with Gbeta 1gamma 2 and/or the Galpha i/o mixture. In membranes of Sf9 cells expressing only h5-ht5A receptors without mammalian G protein subunits, stimulation of the receptors with 5-HT resulted in an increase in [35S]GTPgamma S binding to a maximum of 40% over basal, probably due to the activation of endogenous G proteins. Coexpression of Gbeta 1gamma 2 resulted in a significant increase of the maximum response (Student's t test, P < .05), up to 110% over basal. When the receptor was coexpressed with the mixture of Galpha i/o subunits, without or with Gbeta 1gamma 2, the maximum stimulation was 330 and 570%, respectively. The effect of 5-HT was specific for the h5-ht5A receptor, because 5-HT did not affect [35S]GTPgamma S binding to membranes from uninfected or wild-type baculovirus-infected Sf9 cells (data not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5.   5-HT-stimulated binding of [35S]GTPgamma S to membranes of baculovirus-infected Sf9 cells expressing h5-ht5A receptors alone or in combination with G protein subunits. open circle , h5-ht5A receptors expressed alone. , h5-ht5A receptors coexpressed with the Gbeta 1gamma 2 complex. , h5-ht5A receptors coexpressed with the mixture of Galpha i1, Galpha i2, Galpha i3, and Galpha o subunits. black-square, h5-ht5A receptors coexpressed with the Gbeta 1gamma 2 complex and the mixture of Galpha i1, Galpha i2, Galpha i3, and Galpha o subunits. Membranes were preincubated with compound for 30 min at 30°C and incubated with 0.2 nM [35S]GTPgamma S for an additional 30 min at 30°C. Basal [35S]GTPgamma S binding was measured in the absence of 5-HT, and the percentage of stimulation was calculated as defined in Experimental Procedure. Depicted points are mean ± S.D. values from two to five independent experiments, each performed in duplicate. Mean pEC50 and maximum stimulation values are summarized in Table 3.

Mean pEC50 and maximum stimulation values for 5-HT, tested on a series of 26 receptor/G protein combinations expressed in Sf9 cells, are summarized in Table 3. Coexpressions with the individual Galpha i1, Galpha i2, Galpha i3, or Galpha o subunits yielded maximum responses that were comparable with those for the Galpha i/o mixture. For the Galpha i subunits, additional coexpression of Gbeta 1gamma 2 markedly increased stimulation of [35S]GTPgamma S binding, as observed for the Galpha i/o mixture (Table 3). For Galpha o, however, coexpression with Gbeta 1gamma 2 significantly (Student's t test, P < .05) decreased the maximum stimulation of [35S]GTPgamma S binding. It should be noted that the absolute values for basal [35S]GTPgamma S binding (in cpm) were 2.6-fold higher for Galpha o/Gbeta 1gamma 2 than for Galpha i/Gbeta 1gamma 2 when coexpressed with h5-ht5A receptors, in contrast to coexpressions with Galpha i or Galpha o, which showed comparable levels of agonist-independent [35S]GTPgamma S binding (data not shown). For the coexpressions including Galpha z, Galpha s, Galpha q, Galpha 11, and Galpha 16, a small 5-HT-induced stimulation of [35S]GTPgamma S binding was detected, but the maximum stimulation was never significantly higher than the appropriate control sample. No stimulation was observed for the Galpha 12 and Galpha 13 coexpressions.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3
Stimulation by 5-HT of [35S]GTPgamma S (0.2 nM) binding to membranes of Sf9 cells coexpressing the h5-ht5A receptor and G protein subunits of the Gi/o, Gs, Gq/11, and G12/13 family

[35S]GTPgamma S binding studies were performed as described in Experimental Procedures. The maximum stimulation and pEC50 values were derived from the curves. The results are mean ± S.D. values from n independent experiments.

Modulation of [35S]GTPgamma S Binding by 5-HT Receptor Ligands. Several 5-HT receptor ligands were examined for their ability to modulate [35S]GTPgamma S binding to membranes of Sf9 cells, expressing h5-ht5A receptors with Gbeta 1gamma 2 and either Galpha i1, Galpha i2, Galpha i3, or Galpha o. Figure 6 shows, as an example, the mean curves for the coexpression of h5-ht5A receptors with Galpha i1 and Gbeta 1gamma 2. Table 4 summarizes the pEC50, Emax, pIC50-corr, and Imax values from all [35S]GTPgamma S dose-response and inhibition curves.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   [35S]GTPgamma S binding to membranes of baculovirus-infected Sf9 cells coexpressing h5-ht5A receptors with the Gbeta 1gamma 2 complex and Galpha i1 subunits. A, stimulation of [35S]GTPgamma S binding by 5-HT receptor agonists. B, antagonism of 5-HT (10 µM)-stimulated [35S]GTPgamma S binding by 5-HT receptor ligands. Membranes were preincubated with 5-HT for 30 min at 30°C and incubated with 0.2 nM [35S]GTPgamma S for an additional 30 min at 30°C. Basal [35S]GTPgamma S binding was measured in the absence of compounds, and the percentage of stimulation was calculated as defined in Experimental Procedures. Depicted points are mean ± S.D. values from two to seven independent experiments, each performed in duplicate. Mean pEC50, Emax, pIC50-corr, and Imax values are summarized in Table 4.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 4
Effect of various 5-HT receptor ligands on [35S]GTPgamma S (0.2 nM) binding to membranes of Sf9 cells coexpressing the h5-ht5A receptor and G protein subunits of the Gi/o family

[35S]GTPgamma S binding studies were performed on membranes as described in Experimental Procedures. pEC50 and pIC50 values were derived from the curves. Emax values and Imax values were calculated, and pIC50 values were corrected into pIC50-corr values as described under Experimental Procedures. The results are mean ± S.D. values from n independent experiments.

For each of the coexpressed combinations tested, 5-CT and 5-MT produced maximum responses similar to 5-HT, confirming their full agonistic properties (Francken et al., 1998). DHE and LSD stimulated [35S]GTPgamma S binding to about 50% of the 5-HT level for the Gi coexpressions (i.e., behaved as partial agonists), whereas for the Go coexpression, maximum stimulation approached the level of 5-HT (i.e., DHE and LSD behaved as full agonists). Methiothepin behaved as an inverse agonist as it inhibited [35S]GTPgamma S binding to about -10% below its basal level (5-HT level set at 100%) for Galpha i1, Galpha i2, or Galpha i3 and to -24% below its basal level for Galpha o (see Fig. 6 for Galpha i1; data not shown for Galpha i2, Galpha i3, and Galpha o). However, no reproducible curves could be derived from the methiothepin data points. The antagonistic properties of DHE, LSD, and methiothepin were investigated using [35S]GTPgamma S binding to membranes of the same four coexpressions. DHE and LSD inhibited 5-HT (10 µM)-stimulated [35S]GTPgamma S binding to the level of their own agonistic effect. Methiothepin behaved again as an inverse agonist, inhibiting [35S]GTPgamma S binding below the basal level.

    Discussion
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Little is known about the pharmacological and functional properties of cloned 5-ht5 receptors. Recently, h5-ht5A receptors were shown to mediate inhibition of adenylate cyclase activity in transfected HEK 293 cells (Francken et al., 1998; Hurley et al., 1998). High-affinity agonist binding and agonist-stimulated [35S]GTPgamma S binding to h5-ht5A-HEK 293 membranes were found to be pertussis toxin-sensitive (Francken et al., 1998), indicating the involvement of Gi/Go proteins. To provide further insight in its signaling properties, we coexpressed the h5-ht5A receptor in Sf9 insect cells with a series of 11 mammalian G proteins, from each of the four Galpha families. Using radioligand and [35S]GTPgamma S binding assays, we demonstrated selective coupling of the h5-ht5A receptor to coexpressed Gi and Go proteins and the absence of coupling to Gz/Gs/Gq/G11/G16/G12 and G13 proteins. Hence, the h5-HT5A receptor does not show promiscuous coupling to various G protein families. Although no clear coupling preference to either of the Gi/Go subtypes was evident, we have observed differences in the coupling behavior of Go versus Gi.

The overexpression in Sf9 cells of h5-ht5A receptors alone resulted in a predominantly uncoupled phenotype, as demonstrated by guanine nucleotide-insensitive, low-affinity agonist binding. Although not evident from the binding data, h5-ht5A receptors coupled to endogenous G proteins to some extent; 5-HT stimulated [35S]GTPgamma S binding to 40% over basal. We conclude that a large excess of uncoupled receptors is present in h5-ht5A-Sf9 membranes. Although the activation of G proteins by a small fraction of coupled receptors can be detected due to the sensitivity of the [35S]GTPgamma S binding assay, the curve-fitting algorithms for the concentration-binding isotherms cannot reliably detect a high-affinity binding component of less than 10% of the Bmax value.

When the h5-ht5A receptor was coexpressed with Gi1/Gi2/Gi3 or Go proteins (Galpha beta 1gamma 2 heterotrimers), the coupled phenotype was achieved, as evident from guanine nucleotide-sensitive, high-affinity agonist binding. In addition, the affinity of methiothepin, which was identified as an inverse agonist at h5-ht5A-HEK 293 cells (Francken et al., 1998), decreased on coexpression of Gi/Go proteins. These observations are consistent with two distinct states of the h5-ht5A receptor, according to the two-state model (Leff, 1995). Receptors are proposed to exist in an active form (R*) that is G protein-coupled and an inactive form (R). Agonists show high affinity for R* and low affinity for R, whereas inverse agonists display the opposite behavior (Milligan et al., 1995). Our binding data suggest that h5-ht5A receptors expressed in Sf9 cells convert to the active, high agonist affinity state (R*) through interaction with coexpressed Gi/Go proteins. Remarkably, the affinities of DHE and LSD, which were identified as partial agonists at h5-ht5A-HEK 293 cells, decreased on coexpression of Gi and/or Go proteins. This observation might indicate that the two-state model of agonist action is not generally applicable to partial agonists.

Evidence for h5-ht5A receptor-mediated Gi/Go protein activation was obtained using [35S]GTPgamma S assays. The maximum level of 5-HT-stimulated [35S]GTPgamma S binding to coexpressed Go proteins was similar to that found for h5-ht5A-HEK 293 cells, whereas Gi1/Gi2/Gi3 and the mixture of Gi/o proteins were stimulated by 5-HT with approximately 4-fold higher efficacy. The lower level of 5-HT-mediated stimulation of Go, compared with Gi, might be explained by the 2.6-fold higher basal [35S]GTPgamma S binding that was found for coexpressed Go. This high agonist-independent [35S]GTPgamma S binding most probably originates from a larger number of Go proteins in the Sf9 membranes compared with Gi, as Galpha o appeared more abundant than the various Galpha i subunits in immunoblot analysis. Alternatively, the h5-ht5A receptor may exhibit stronger constitutive activation of Go, compared with Gi. High agonist-independent binding complicates the detection of agonist-induced increases in [35S]GTPgamma S binding (Wieland and Jakobs, 1994). It could be that the assay conditions (e.g., buffer composition and incubation temperature) optimal for Go activation differ from the applied conditions, such that the actual maximum stimulation of Go by 5-HT might well be higher than reported.

Coexpression of the h5-ht5A receptor with one of the other G proteins tested (Gz/Gs/Gq/G11/G16/G12 or G13) had no effect on agonist binding, and no or only minor 5-HT-induced activation of these G proteins could be detected. The expression of the different heterologous Galpha proteins in the Sf9 membranes was confirmed using immunoblotting. All Galpha proteins were highly expressed, and only Galpha 12 showed weak immunoreactivity. Hence, poor subunit expression is not the reason for the absence of effects for the various G proteins, except perhaps for Galpha 12. It should be noted that in the [35S]GTPgamma S studies, the assay conditions were not optimized for each individual G protein type. Under the applied conditions, which were optimized for [35S]GTPgamma S binding to h5-ht5A-HEK 293 membranes, activation of some G protein types may therefore be suboptimal. As the need to optimize assay conditions for individual G proteins has been reported previously (Wieland and Jacobs, 1994), it would be rash to conclude the absolute absence of h5-ht5A receptor coupling to Gz/Gs/Gq/G11/G16/G12 or G13 proteins based exclusively on the absence of increases in [35S]GTPgamma S binding. The lack of receptor interaction with these G proteins is only suggested by the fact that coexpression of these G proteins did not induce guanine nucleotide-sensitive, high-affinity agonist binding to the h5-ht5A receptor. It appears that h5-ht5A receptors selectively couple to Gi/Go proteins, which is in agreement with the finding that pertussis toxin pretreatment completely abolished high-affinity agonist binding and 5-HT-stimulated [35S]GTPgamma S binding to h5-ht5A-HEK 293 membranes (Francken et al., 1998).

The Gbeta gamma complex has already been shown to be required for optimal receptor-G protein interaction (Fung, 1983; Butkerait et al., 1995). We have used the Gbeta 1gamma 2 dimer to enhance G protein coupling to the h5-ht5A receptor, because this dimer was reported to interact with members of the four Galpha families (Barr et al., 1997). However, the subunit composition of Gbeta gamma affects receptor-G protein coupling specificity (Kisselev and Gautam, 1993; Kleuss et al., 1993; Richardson and Robishaw, 1999), such that other Gbeta gamma subunit compositions may yield different receptor coupling profiles. Therefore, we also investigated h5-ht5A receptor-G protein coupling in the absence of the mammalian Gbeta 1gamma 2 complex. The interaction of receptor with Galpha i1, Galpha i2, and Galpha i3 could still be detected in agonist binding and [35S]GTPgamma S assays, but it was indeed less effective than that in the presence of Gbeta 1gamma 2. Remarkably, coexpression with Galpha o did not induce high-affinity agonist binding in the absence of Gbeta 1gamma 2. Previously, Jockers et al. (1994) found similar results for adenosine A1 receptors expressed in Escherichia coli; reconstitution of high-affinity agonist binding by purified G proteins was poor in the absence of Gbeta gamma for Go, but not for Gi, whereas in the presence of Gbeta gamma , their maximum responses were similar. Despite the lack of effect on agonist affinity of Galpha o, the activation of h5-ht5A receptors produced a maximum stimulation of [35S]GTPgamma S binding similar to Galpha i subunits. Coexpression of h5-ht5A receptors and either Galpha z/Galpha s/Galpha q/Galpha 11/Galpha 16/Galpha 12 or Galpha 13 without Gbeta 1gamma 2 did not result in the coupled phenotype, as expected from the lack of effect when Galpha beta 1gamma 2 heterotrimers were expressed. We conclude that the Gbeta 1gamma 2 complex greatly facilitates coupling of Gi/o proteins to the h5-ht5A receptor when coexpressed in Sf9 cells.

Coexpression of h5-ht5A receptors and Gbeta 1gamma 2 without mammalian Galpha subunits revealed that Gbeta 1gamma 2 enhances interaction of heterologous receptor with insect G proteins. Similar results were reported for the serotonin 5-HT1A and the dopamine D2S receptor (Butkerait et al., 1995; Boundy et al., 1996). Considering this finding, one should note that an improved interaction of recombinant receptors with endogenous G proteins due to coexpressed Gbeta 1gamma 2 subunits may confuse the interpretation of receptor-G protein interaction specificity. Regardless, it is clear that the overexpression of specifically interacting G proteins should yield effects that exceed these observed for the appropriate controls.

For some receptors that couple to pertussis toxin-sensitive G proteins, preferential interaction with one of the Gi/Go subtypes has been demonstrated (Senogles et al., 1990; Parker et al., 1991; Rubinstein et al., 1991; Grünewald et al., 1996; Clawges et al., 1997; Lorenzen et al., 1998). Our data indicate that the heterotrimeric Gi1, Gi2, Gi3, or Go proteins interacted equally well with the h5-ht5A receptor to induce its high-affinity conformation, and no significant differences in the affinities of the tested compounds were observed. However, in contrast to Galpha i, Galpha o did not induce high-affinity agonist binding in the absence of Gbeta 1gamma 2, suggesting diminished receptor interaction. Furthermore, some striking differences between Go and Gi proteins appeared from the [35S]GTPgamma S experiments. Maximum stimulation of [35S]GTPgamma S binding by 5-HT was significantly lower at Go than at Gi, possibly due to the high agonist-independent [35S]GTPgamma S binding to Go. In addition, the relative efficacies of DHE and LSD were dependent on the G protein type expressed. Both compounds were full agonists at the h5-ht5A receptor when coexpressed with Go, whereas coexpression with Gi proteins resulted in partial agonistic behavior, which was also found at the h5-HT5A-HEK 293 membranes (Francken et al., 1998). These data might be explained by a difference in receptor/G protein stoichiometry, which can influence both agonist potency and efficacy (Hermans et al., 1999). Alternatively, the efficacy of compounds may be determined by the type of G protein interacting with the receptor. In this respect, Yang and Lanier (1999) have reported that recombinant expression of Galpha o, but not Galpha i1, increased the relative efficacy of clonidine in NIH-3T3 cells cotransfected with alpha 2-adrenergic receptor and Galpha subunit, an effect that was not an issue of G protein or receptor levels. Although we cannot exclude that differences in h5-ht5A receptor-to-G protein ratio cause the distinct behavior of Go and Gi proteins, it is tempting to speculate that structural differences exist in their interaction with the h5-HT5A receptor. However, differences in the nucleotide binding properties of the G protein types themselves should also be taken into account; as such, Go may be easier to activate by receptors than Gi.

In summary, the h5-HT5A receptor selectively coupled to mammalian Gi1/Gi2/Gi3 and Go but not to Gz/Gs/Gq/11/16 or G12/13 proteins, when coexpressed in Sf9 insect cells. Although Go displayed different receptor coupling characteristics than Gi proteins, no clear coupling preference was evident.

    Acknowledgments

We thank Dr. Menelas Pangalos and Liesbet van der Helm for cloning of the h5-ht5A receptor cDNA and Isolde Peters and Hubert Hamelink for their practical assistance in the binding studies. We also thank Jurgen Vanhauwe and Dr. Reginald Brys for helpful discussion and suggestions. We are grateful to Drs. J. Garrison, D. Manning, A. Gilman, T. Kozasa, D. Dhanasekaran, and T. Haga for kindly providing G protein subunit recombinant transfer vectors or baculoviruses.

    Footnotes

Received July 12, 1999; Accepted January 6, 2000

This work was supported by a grant from the IWT (Vlaams Instituut voor de Bevordering van het Wetenschappelijk-Technologisch Onderzoek in de Industrie).

Send reprint requests to: Dr. Josée E. Leysen, Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium. E-mail: jleysen2{at}janbe.jnj.com

    Abbreviations

5-HT, 5-hydroxytryptamine (serotonin); GTPgamma S, guanosine-5'-O-(3-thio)triphosphate; 5-CT, 5-carboxamidotryptamine; 5-MT, 5-methoxytryptamine; DHE, dihydroergotamine; Emax, relative maximum stimulation; G protein, guanine nucleotide-binding protein; Gi/o, combination of Gi1, Gi2, Gi3, and Go proteins; Gpp(NH)p, guanosine-5'-(beta ,gamma -imido)triphosphate; Galpha , G protein alpha -subunit; Gbeta 1gamma 2, G protein beta 1gamma 2 dimer; h5-ht5A, human 5-hydroxytryptamine type 5A; HEK, human embryonic kidney; IC50-corr, corrected IC50; Imax, relative maximum inhibition; LSD, lysergic acid diethylamide; m.o.i., multiplicity of infection; Sf9, Spodoptera frugiperda 9.

    References
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References


0026-895X/00/051034-11$3.00/0
MOLECULAR PHARMACOLOGY, 57:1034-1044 (2000).
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J Biomol ScreenHome page
W. R. Leifert, A. L. Aloia, O. Bucco, R. V. Glatz, and E. J. McMurchie
G-Protein-Coupled Receptors in Drug Discovery: Nanosizing Using Cell-Free Technologies and Molecular Biology Approaches
J Biomol Screen, December 1, 2005; 10(8): 765 - 779.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
K. Masuda, H. Itoh, T. Sakihama, C. Akiyama, K. Takahashi, R. Fukuda, T. Yokomizo, T. Shimizu, T. Kodama, and T. Hamakubo
A Combinatorial G Protein-coupled Receptor Reconstitution System on Budded Baculovirus: EVIDENCE FOR G{alpha}i AND G{alpha}o COUPLING TO A HUMAN LEUKOTRIENE B4 RECEPTOR
J. Biol. Chem., June 27, 2003; 278(27): 24552 - 24562.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Azzi, G. Pineyro, S. Pontier, S. Parent, H. Ansanay, and M. Bouvier
Allosteric Effects of G Protein Overexpression on the Binding of beta -Adrenergic Ligands with Distinct Inverse Efficacies
Mol. Pharmacol., November 1, 2001; 60(5): 999 - 1007.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francken, B. J. B.
Right arrow Articles by Leysen, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francken, B. J. B.
Right arrow Articles by Leysen, J. E.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics